Nobel Biocare Distributes Updated Information to Regulatory Bodies and Customers On NobelDirect and NobelPerfect One-Piece Implant
ZURICH, Switzerland, Jan. 31, 2008 (PRIME NEWSWIRE) -- The Swedish Medical Product Agency (MPA) and Nobel Biocare (Other OTC:NBCHF) have agreed the wording of a field safety notice, which will be issued today to all regulatory bodies worldwide and to Nobel Biocare customers. The field safety notice is a consequence of clarifications and changes needed to the Instruction For Use.